Abstract
The detailed mechanisms responsible for processing tumor-associated antigens and presenting them to CTLs remain to be fully elucidated. In this study, we demonstrate a unique CTL epitope generated from the ubiquitous protein puromycin-sensitive aminopeptidase, which is presented via HLA-A24 on leukemic and pancreatic cancer cells but not on normal fibroblasts or EBV-transformed B lymphoblastoid cells. The generation of this epitope requires proteasomal digestion and transportation from the endoplasmic reticulum to the Golgi apparatus and is sensitive to chloroquine-induced inhibition of acidification inside the endosome/lysosome. Epitope liberation depends on constitutively active autophagy, as confirmed with immunocytochemistry for the autophagosome marker LC3 as well as RNA interference targeting two different autophagy-related genes. Therefore, ubiquitously expressed proteins may be sources of specific tumor-associated antigens when processed through a unique mechanism involving autophagy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcysteine / analogs & derivatives
-
Acetylcysteine / pharmacology
-
Aminopeptidases / genetics
-
Aminopeptidases / metabolism
-
Antigens, Neoplasm / immunology
-
Autophagy / genetics
-
Autophagy / immunology*
-
Cell Line, Tumor
-
Epitopes / drug effects
-
Epitopes / genetics
-
Epitopes / immunology*
-
Fibroblasts / immunology
-
HLA-A24 Antigen / genetics
-
HLA-A24 Antigen / immunology*
-
Humans
-
Leukemia / immunology
-
Leukemia / pathology
-
Molecular Mimicry
-
Pancreatic Neoplasms / immunology
-
Pancreatic Neoplasms / pathology
-
RNA Interference
-
Recombinant Proteins / genetics
-
Recombinant Proteins / immunology
-
Recombinant Proteins / metabolism
-
T-Lymphocytes, Cytotoxic / immunology*
-
Vacuoles / metabolism
Substances
-
Antigens, Neoplasm
-
Epitopes
-
HLA-A24 Antigen
-
Recombinant Proteins
-
lactacystin
-
Aminopeptidases
-
enkephalin degrading enzyme
-
Acetylcysteine
Grants and funding
This work is supported by the Third Team Comprehensive Control Research for Cancer (no. 29) from the Ministry of Health, Labor and Welfare, Japan, by Grants-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 23701079), and Hayashi Memorial Foundation for Female Natural Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.